Algeria vs Iran: Patent applications, nonresidents
Patent applications, nonresidents over time
- Algeria
- Iran
How they compare
Algeria currently reports 581 against 581 in Iran, a difference of 0.
The two have swapped places 12 times across 36 shared years of data; in 1980 it was Iran ahead.
Algeria ranks 40th and Iran ranks 40th of 150 countries.
Across the 5 decades both report, Algeria averaged higher in 3 and Iran in 2.
Head to head by decade
| Decade | Algeria | Iran | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 290.43 | 288.86 | 1.57 | Algeria |
| 1990s | 182.5 | 161.5 | 21 | Algeria |
| 2000s | 372.88 | 375.75 | 2.88 | Iran |
| 2010s | 662.33 | 566.22 | 96.11 | Algeria |
| 2020s | 564 | 607.5 | 43.5 | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher patent applications, nonresidents, Algeria or Iran?
- Algeria, at 581 against 581 in Iran as of 2021.
- What is the difference in patent applications, nonresidents between Algeria and Iran?
- 0, with Algeria ahead.
- How many years of comparable data are there for Algeria and Iran?
- 36 years are reported by both, from 1980 to 2021.
- How do Algeria and Iran rank globally for patent applications, nonresidents?
- Algeria ranks 40th and Iran ranks 40th of 150 countries.
- Where does this data come from?
- WIPO Patent Report: Statistics on Worldwide Patent Activity, World Intellectual Property Organization (WIPO), note: The International Bureau of WIPO assumes no responsibility with respect to the trans, published as Patent applications, nonresidents. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Patent applications are worldwide patent applications filed through the Patent Cooperation Treaty procedure or with a national patent office for exclusive rights for an invention--a product or process that provides a new way of doing something or offers a new technical solution to a problem. A patent provides protection for the invention to the owner of the patent for a limited period, generally 20 years.